Carbamic Acid

Carbamic Acid

SCHEMBL5718035

NC(=O)O.c1ccc(C2CCCCC2)cc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMO O15229 1/20 0.58
▸ SLC18A3 Q16572 5/20 0.52
▸ CYP11B2 P19099 1/20 0.50
▸ KDM4E B2RXH2 2/20 0.49
▸ HAO1 Q9UJM8 1/20 0.49
▸ AKR1C3 P42330 1/20 0.48
▸ AKR1C1 Q04828 1/20 0.48
▸ KIF11 P52732 1/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ CYP2D6 P10635 2/20 0.47
▸ SIGMAR1 Q99720 2/20 0.47
▸ TSHR P16473 2/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ GLA P06280 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ HIF1A Q16665 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbamic Acid SCHEMBL31509470 1.00 KMO (0.58) KMOSLC18A3CYP11B2KDM4EHAO1
Bicarbonate SCHEMBL4410582 0.91 KMO (0.61) KMOSLC18A3CYP11B2KDM4EHAO1
Bicarbonate SCHEMBL4407651 0.91 KMO (0.61) KMOSLC18A3CYP11B2KDM4EHAO1
Bicarbonate SCHEMBL9436080 0.91 KMO (0.61) KMOSLC18A3CYP11B2KDM4EHAO1
Bicarbonate SCHEMBL4412934 0.89 KMO (0.58) KMOSLC18A3HAO1AKR1C3AKR1C1
Carbamic Acid SCHEMBL9679981 0.89 AKR1C3 (0.59) KMOSLC18A3KDM4EAKR1C3AKR1C1
Hydrogen Peroxide SCHEMBL42934 0.89 SLC18A3 (0.61) KMOSLC18A3CYP11B2SMN1; SMN2CYP2D6
Hydrogen Peroxide SCHEMBL5901852 0.89 SLC18A3 (0.61) KMOSLC18A3CYP11B2SMN1; SMN2CYP2D6
Hydrogen Peroxide SCHEMBL9997756 0.89 SLC18A3 (0.61) KMOSLC18A3CYP11B2SMN1; SMN2CYP2D6
Hydrogen Peroxide SCHEMBL2352896 0.89 SLC18A3 (0.61) KMOSLC18A3CYP11B2SMN1; SMN2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1318977-B1 SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID AMIDES AND THE USE THEREOF BAYER HEALTHCARE AG (DE) 2006-12-06 — — EP disclosed
EP-1318977-B1 SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID AMIDES AND THE USE THEREOF BAYER HEALTHCARE AG (DE) 2006-12-06 — — EP disclosed
EP-1187812-B1 SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID AMIDES AND THEIR USE AS ADENOSINE UPTAKE INHIBITORS BAYER HEALTHCARE AG (DE) 2005-09-07 — — EP disclosed
EP-1187812-B1 SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID AMIDES AND THEIR USE AS ADENOSINE UPTAKE INHIBITORS BAYER HEALTHCARE AG (DE) 2005-09-07 — — EP disclosed
EP-1436273-A1 SUBSTITUTED PIPERAZINE CYCLOHEXANE CARBOXILIC ACID AMIDES AND THE USE THEREOF Bayer HealthCare AG (DE) 2004-07-14 — — EP disclosed
EP-1318977-A1 SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID AMIDES AND THE USE THEREOF Bayer Aktiengesellschaft (DE) 2003-06-18 — — EP disclosed
EP-1318977-A1 SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID AMIDES AND THE USE THEREOF Bayer Aktiengesellschaft (DE) 2003-06-18 — — EP disclosed
EP-1185516-B1 SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID AMIDES THAT HAVE AN ADENOSINE UPTAKE INHIBITING EFFECT BAYER AG (DE) 2003-05-02 — — EP disclosed
EP-1185516-B1 SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID AMIDES THAT HAVE AN ADENOSINE UPTAKE INHIBITING EFFECT BAYER AG (DE) 2003-05-02 — — EP disclosed
WO-2003033484-A1 SUBSTITUTED PIPERAZINE CYCLOHEXANE CARBOXILIC ACID AMIDES AND THE USE THEREOF BAYER HEALTHCARE AG (DE) 2003-04-24 — — WO disclosed
EP-1187812-A2 SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID AMIDES AND THEIR USE AS ADENOSINE UPTAKE INHIBITORS Bayer Aktiengesellschaft (DE) 2002-03-20 — — EP disclosed
WO-2002020472-A1 SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID AMIDES AND THE USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2002-03-14 — — WO disclosed
WO-2002020472-A1 SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID AMIDES AND THE USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2002-03-14 — — WO disclosed
EP-1185516-A1 SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID AMIDES THAT HAVE AN ADENOSINE UPTAKE INHIBITING EFFECT Bayer Aktiengesellschaft (DE) 2002-03-13 — — EP disclosed
EP-1185516-A1 SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID AMIDES THAT HAVE AN ADENOSINE UPTAKE INHIBITING EFFECT Bayer Aktiengesellschaft (DE) 2002-03-13 — — EP disclosed
WO-2000073274-A3 SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID AMIDES AND THEIR USE AS ADENOSINE UPTAKE INHIBITORS BAYER AG (DE) 2001-04-19 — — WO disclosed
WO-2000073274-A2 SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID AMIDES AND THEIR USE AS ADENOSINE UPTAKE INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2000-12-07 — — WO disclosed
WO-2000073275-A1 SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID AMIDES THAT HAVE AN ADENOSINE UPTAKE INHIBITING EFFECT BAYER AKTIENGESELLSCHAFT (DE) 2000-12-07 — — WO disclosed
WO-2000073275-A1 SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID AMIDES THAT HAVE AN ADENOSINE UPTAKE INHIBITING EFFECT BAYER AKTIENGESELLSCHAFT (DE) 2000-12-07 — — WO disclosed
WO-2000073274-A2 SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID AMIDES AND THEIR USE AS ADENOSINE UPTAKE INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2000-12-07 — — WO disclosed
Send feedback